T790M Mutation Testing in Blood by Different Methodologies
NCT03363139
·
clinicaltrials.gov ↗
COMPLETED
Status
72
Enrollment
OTHER
Sponsor class
Conditions
NSCLC Stage IV
Interventions
DRUG:
Tirosin Kinase Inhibitors
Sponsor
Spanish Lung Cancer Group